Standout Papers

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum V... 2012 2026 2016 2021 798
  1. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer (2016)
    Martin Reck, Alexander Luft et al. Journal of Clinical Oncology
  2. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial (2015)
    Nick Thatcher, Fred R. Hirsch et al. The Lancet Oncology
  3. Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study (2012)
    Thomas J. Lynch, Igor Bondarenko et al. Journal of Clinical Oncology

Immediate Impact

17 by Nobel laureates 18 from Science/Nature 110 standout
Sub-graph 1 of 19

Citing Papers

Androgen receptor activity in T cells limits checkpoint blockade efficacy
2022 StandoutNature
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
2022 StandoutNature
2 intermediate papers

Works of Alexander Luft being referenced

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
2016 Standout
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
2012 Standout

Author Peers

Author Last Decade Papers Cites
Alexander Luft 1447 695 55 484 21 1.7k
Raju Titus Chacko 1309 501 87 573 38 1.6k
Alexander Luft 1925 987 77 344 35 2.2k
Philip D. Leming 1475 567 92 596 21 1.8k
Vamsidhar Velcheti 1077 431 80 588 32 1.3k
Robert A. Somer 923 406 47 252 32 1.2k
Julian A. Marin‐Acevedo 1099 342 77 720 26 1.6k
Yang Wang 941 404 152 587 19 1.6k
David Vicente 1262 817 87 211 46 1.5k
Hui Yu 1790 923 149 640 39 2.3k
Amit Panwalkar 1500 1001 120 332 29 1.9k

All Works

Loading papers...

Rankless by CCL
2026